Common anti-diabetic drug shows potential in improving outcome after stroke

People with type 2 diabetes have an increased risk of stroke and a worsened outcome after suffering from it. Now, researchers at the Karolinska Institutet have shown that stroke outcome is significantly improved in mice with obesity and type 2 diabetes who have been treated with the commonly used diabetic drugs SGLT-2 inhibitors.

Leave A Comment

Your email address will not be published. Required fields are marked *